Contrad Swiss is a healthcare company focused on the identification, development and commercialization of innovative products, technologies and brands.Since 2011, Contrad has focused on identifying innovative healthcare products with strong potential for EAEU and CIS markets.Combining scientific evaluation with commercial execution, Contrad creates, develops and grows healthcare brands through product development, positioning, clinical strategy, regulatory planning and commercialization.
Contrad operates through a selective project development model.
Rather than pursuing broad portfolio expansion, the company focuses on opportunities that demonstrate meaningful differentiation, scientific rationale and long-term commercial potential.
Contrad identifies promising products and technologies, develops commercial strategies around them and builds healthcare brands designed for sustainable growth.
Depending on their maturity and strategic objectives, projects may remain within Contrad or continue through dedicated structures focused on their future development.